Loading…
Is Thyroid Cancer Recurrence Risk Increased After Transplantation?
Context: An increased cancer mortality is reported in transplanted patients. Objective: This multicentric study aimed to investigate the rate of thyroid cancer recurrence after transplantation. Results: Sixty-eight patients (35 male/33 female) with a history of both thyroid cancer and organ transpla...
Saved in:
Published in: | The journal of clinical endocrinology and metabolism 2013-10, Vol.98 (10), p.3981-3988 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Context:
An increased cancer mortality is reported in transplanted patients.
Objective:
This multicentric study aimed to investigate the rate of thyroid cancer recurrence after transplantation.
Results:
Sixty-eight patients (35 male/33 female) with a history of both thyroid cancer and organ transplantation were recruited via two nationwide French networks. Histological analysis identified 58 papillary (88%), 5 follicular (7.5%), and 3 poorly differentiated cancer cases (4.5 %). Thirty-one patients (52%) presented high recurrence risk tumors. In the 36 patients with thyroid cancer diagnosed after transplantation, the 5-year disease-free survival (DFS) was 74.7% (SE: 7.3%). One patient died after progression of a poorly differentiated cancer. Persistent disease was observed in six high-risk patients. One of them underwent a second transplantation and disease remained stable after 5 years of follow-up. Thyroid cancer had been diagnosed before transplantation in 32 patients. One patient with cystic fibrosis and thyroid lung metastases at the time of lung transplantation underwent a 4-year remission. For the 31 patients in remission at the time of transplantation, the 5-year DFS was 93.1% (SE: 4.8%). Two patients with local recurrence presented subsequent remission. For the entire study population, the 5-year and 9-year DFS were 81.9% (SE: 5.5%) and 75.6% (SE: 7.9%), respectively. Recurrence or persistent disease occurred in patients with high-risk tumors.
Conclusions:
The prognosis of thyroid cancer does not seem to be altered by transplantation. This suggests that a history of thyroid cancer should not be considered a contraindication. |
---|---|
ISSN: | 0021-972X 1945-7197 |
DOI: | 10.1210/jc.2013-1357 |